Ameriprise
MYOK

Ameriprise’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Ameriprise’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-512,165
Closed -$69.8M – 3887
2020
Q3 		$69.8M Buy
512,165
+488,669
+2,080% +$52M 0.03% 527
2020
Q2 		$2.27M Buy
23,496
+4,931
+27% +$411K ﹤0.01% 2543
2020
Q1 		$870K Sell
18,565
-495
-3% -$31.7K ﹤0.01% 2880
2019
Q4 		$1.39M Buy
19,060
+1,580
+9% +$95.8K ﹤0.01% 2922
2019
Q3 		$911K Sell
17,480
-3,070
-15% -$163K ﹤0.01% 3052
2019
Q2 		$1.03M Buy
20,550
+160
+0.8% +$7.79K ﹤0.01% 3055
2019
Q1 		$1.06M Buy
+20,390
New +$939K ﹤0.01% 3020
2018
Q2 		– Sell
-19,700
Closed -$961K – 3733
2018
Q1 		$961K Buy
+19,700
New +$1.02M ﹤0.01% 2988
2017
Q4 		– Sell
-34,009
Closed -$1.46M – 3773
2017
Q3 		$1.46M Buy
+34,009
New +$1.08M ﹤0.01% 2783

Ameriprise's MYOK Position: Q4 2020 in Review

Ameriprise sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 512,165 shares — an estimated $69.8M sold.

Ameriprise first reported a position in MYOK in Q3 2017 and held it in 9 quarters. The position peaked at $69.8M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Ameriprise reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Ameriprise sold 512,165 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $69.8M.
  • Ameriprise first reported a position in MyoKardia, Inc. Common Stock in Q3 2017 and held it in 9 quarters.
  • Ameriprise's MyoKardia, Inc. Common Stock position peaked at $69.8M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Ameriprise's 13F filing for Q4 2020, filed 12 Feb 2021.